These findings indicated that Daphnetin may limit the formation and progression of experimental aneurysms by inhibiting mural inflammation and angiogenesis through targeting NF-κB signaling pathways include TNF-α-induced IκBα degradation, IKK phosphorylation, and NF-κB-P65 protein translocation. The gene discussed is NFKB1; the disease is aneurysm.